EFPIA Newsletter 04 November 2021

AMR: Let's find the solutions Superbugs could set medicine back to the 19th century, before the discovery of penicillin, when simple infections could kill. How can we ensure there is a sustainable pipeline of new antimicrobials?

Blogs     02 November 2021 Lung Cancer Awareness Month: The importance of the patient perspective in driving advancements... Reducing the burden of lung cancer and transforming long-term outcomes for patients Read more →         29 October 2021 What does it take to get the world vaccinated against COVID-19? The real path to global vaccine equity Read more →

Making the impossible, possible

	IFPMA Science, collaboration and innovation made it possible to have several COVID-19 vaccines in one year and #WeWontRest until there is a COVID-19 vaccine for everyone.		Vaccines Europe Using mRNA technology to develop vaccines was once impossible, but thanks to 40 years of research it's now possible. It's made protecting citizens against COVID-19 possible. Together we're making the impossible, possible. #WeWontRest

Events     09 NOV 2021   Investigating the syndemic threat of COVID-19 and chronic disease: The diabetes case... Virtual event Improved integration of care is the way forward to strengthen chronic disease management in emergencies and beyond Learn more →       09 NOV 2021   Joint EFPIA & EFGCP “Good Lay Summary Practice” Recommendations Virtual event The new tool you should use to comply with the European Clinical Trial Regulation (EU No. 536/2014) Learn more →

	16 NOV 2021			Pandemic Prevention: how Europe can lead the fight against AMR Virtual event The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. Learn more →

	29 MAR 2022			DIA Europe 2022 Hybrid conference (virtual - Brussels) Advancing Health Priorities Learn more →

COP26: How pharmaceutical companies are helping the fight against climate change Find out what our companies are working on.

What we are reading Pharma Companies Launch Supplier Program to Advance Climate Action 04 November 2021  (Schneider Electric) Read more → New European initiative will build a collaborative platform for data and sample sharing, to accelerate... 02 November 2021  (Alzheimer Europe) Read more → Unlocking the potential of mRNA to inform the treatments and vaccines of tomorrow 26 October 2021  (STAT) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe